Related Experiment Videos
The defect in mu heavy chain disease protein GLI
Journal of Immunology (Baltimore, Md. : 1950)
|April 1, 1976
Abstract:
Amino acid sequence studies of muHCD protein GLI reveal the absence of the amino terminal 130 residues. The molecule starts at Ala 131 and contains Cys 140, normally involved in the H-L disulfide bridges. Except for the deletion and presumably an extra H-H disulfide bridge involving Cys 140, the remainder of the mu-chain appears normal.
Insights
Amino acid sequencing of the mu heavy chain constant domain (muHCD) protein GLI shows a deletion of the first 130 residues. The modified mu-chain retains Cys 140, suggesting potential alterations in disulfide bonding and protein structure.
Area of Science:
- Immunology
- Protein Chemistry
- Molecular Biology
Background:
- The mu heavy chain constant domain (muHCD) is a critical component of IgM antibodies.
- Understanding structural variations in muHCD is essential for characterizing antibody function.
Purpose of the Study:
- To investigate the structural integrity and sequence of the muHCD protein GLI.
- To identify any alterations in the amino acid sequence and potential impact on protein structure.
Main Methods:
- Amino acid sequencing of the muHCD protein GLI.
- Analysis of protein sequence data to identify deletions and modifications.
Main Results:
- The muHCD protein GLI lacks the initial 130 amino acid residues, starting instead at Alanine 131.
- Cysteine 140, crucial for heavy-light (H-L) chain disulfide bridges, is present in the truncated protein.
- A potential extra heavy-heavy (H-H) disulfide bridge involving Cysteine 140 is suggested.
- The remaining mu-chain sequence appears structurally normal.
Conclusions:
- The GLI muHCD protein exhibits a significant N-terminal deletion.
- The presence of Cys 140 indicates potential alterations in disulfide bonding patterns within the mu-chain.
- Further studies are warranted to elucidate the functional consequences of this structural modification.